chr1:17490369-17579615 |
chr1:17536952 |
rs2977272 |
PADI1 |
Obesity (extreme) |
intron |
0.000766 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17557178 |
rs2977235 |
PADI1 |
Urinary metabolites |
intron |
1.9e-05 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17559196 |
rs4268393 |
PADI1 |
Urinary metabolites |
intron |
4.6e-06 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17564847 |
rs3003412 |
PADI1 |
Blood pressure (response to angiotensin-converting enzyme inhibitor) |
intron |
0.000385 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17564990 |
rs2977310 |
PADI1 |
Age-related macular degeneration |
intron |
5.28e-05 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17573439 |
rs2977225 |
NA |
Vaspin levels |
NA |
0.000213 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17573439 |
rs2977225 |
NA |
Treatment outcomes for selective serotonin reuptake inhibitors (SSRIs) - response at 8 weeks |
NA |
0.000213 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17573988 |
rs3003419 |
NA |
Blood pressure (response to angiotensin-converting enzyme inhibitor) |
NA |
0.000359 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17576638 |
rs12562867 |
PADI3 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
| chr1:17490369-17579615 |
chr1:17508246 |
rs2254135 |
RCC2 - ARHGEF10L |
Response to hepatitis C treatment |
regulatory_region_variant |
3e-06 |
GWAS_Catalog |
| chr1:17385806-17450353 |
chr1:17394046 |
rs2746533 |
PADI2 |
Menopause (age at onset) |
UTR-3 |
8.23e-05 |
GWASdb |
| chr1:17385806-17450353 |
chr1:17394775 |
rs2235927 |
PADI2 |
Asthma |
UTR-3 |
1.21e-06 |
GWASdb |
| chr1:17385806-17450353 |
chr1:17398849 |
rs3818042 |
PADI2 |
Pulmonary function |
intron |
0.000531 |
GWASdb |
| chr1:17385806-17450353 |
chr1:17410557 |
rs730387 |
PADI2 |
Rheumatoid arthritis |
intron |
9.52e-06 |
GWASdb |
| chr1:17385806-17450353 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
4e-12 |
GWAS_Catalog |
| chr1:17385806-17450353 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
7e-14 |
GWAS_Catalog |
| chr1:17385806-17450353 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
8e-17 |
GWAS_Catalog |
| chr1:17385806-17450353 |
chr1:17418040 |
rs57142672 |
RCC2 |
Basal cell carcinoma |
intron_variant |
1e-23 |
GWAS_Catalog |
| chr1:17386364-17455510 |
chr1:17394046 |
rs2746533 |
PADI2 |
Menopause (age at onset) |
UTR-3 |
8.23e-05 |
GWASdb |
| chr1:17386364-17455510 |
chr1:17394775 |
rs2235927 |
PADI2 |
Asthma |
UTR-3 |
1.21e-06 |
GWASdb |
| chr1:17386364-17455510 |
chr1:17398849 |
rs3818042 |
PADI2 |
Pulmonary function |
intron |
0.000531 |
GWASdb |
| chr1:17386364-17455510 |
chr1:17410557 |
rs730387 |
PADI2 |
Rheumatoid arthritis |
intron |
9.52e-06 |
GWASdb |
| chr1:17386364-17455510 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
4e-12 |
GWAS_Catalog |
| chr1:17386364-17455510 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
7e-14 |
GWAS_Catalog |
| chr1:17386364-17455510 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
8e-17 |
GWAS_Catalog |
| chr1:17386364-17455510 |
chr1:17418040 |
rs57142672 |
RCC2 |
Basal cell carcinoma |
intron_variant |
1e-23 |
GWAS_Catalog |
| chr1:17386320-17468999 |
chr1:17394046 |
rs2746533 |
PADI2 |
Menopause (age at onset) |
UTR-3 |
8.23e-05 |
GWASdb |
| chr1:17386320-17468999 |
chr1:17394775 |
rs2235927 |
PADI2 |
Asthma |
UTR-3 |
1.21e-06 |
GWASdb |
| chr1:17386320-17468999 |
chr1:17398849 |
rs3818042 |
PADI2 |
Pulmonary function |
intron |
0.000531 |
GWASdb |
| chr1:17386320-17468999 |
chr1:17410557 |
rs730387 |
PADI2 |
Rheumatoid arthritis |
intron |
9.52e-06 |
GWASdb |
| chr1:17386320-17468999 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
4e-12 |
GWAS_Catalog |
| chr1:17386320-17468999 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
7e-14 |
GWAS_Catalog |
| chr1:17386320-17468999 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
8e-17 |
GWAS_Catalog |
| chr1:17386320-17468999 |
chr1:17418040 |
rs57142672 |
RCC2 |
Basal cell carcinoma |
intron_variant |
1e-23 |
GWAS_Catalog |
| chr1:17414193-17445888 |
chr1:17418040 |
rs57142672 |
RCC2 |
Basal cell carcinoma |
intron_variant |
1e-23 |
GWAS_Catalog |
| chr1:17389196-17450244 |
chr1:17394046 |
rs2746533 |
PADI2 |
Menopause (age at onset) |
UTR-3 |
8.23e-05 |
GWASdb |
| chr1:17389196-17450244 |
chr1:17394775 |
rs2235927 |
PADI2 |
Asthma |
UTR-3 |
1.21e-06 |
GWASdb |
| chr1:17389196-17450244 |
chr1:17398849 |
rs3818042 |
PADI2 |
Pulmonary function |
intron |
0.000531 |
GWASdb |
| chr1:17389196-17450244 |
chr1:17410557 |
rs730387 |
PADI2 |
Rheumatoid arthritis |
intron |
9.52e-06 |
GWASdb |
| chr1:17389196-17450244 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
4e-12 |
GWAS_Catalog |
| chr1:17389196-17450244 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
7e-14 |
GWAS_Catalog |
| chr1:17389196-17450244 |
chr1:17395867 |
rs7538876 |
PADI6 |
Basal cell carcinoma |
intron_variant |
8e-17 |
GWAS_Catalog |
| chr1:17389196-17450244 |
chr1:17418040 |
rs57142672 |
RCC2 |
Basal cell carcinoma |
intron_variant |
1e-23 |
GWAS_Catalog |